Literature DB >> 10713679

Mouse models for breast cancer.

L Hennighausen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10713679     DOI： 10.1038/sj.onc.1203346

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


× No keyword cloud information.
  8 in total

Review 1.  Interrogating mouse mammary cancer models: insights from gene expression profiling.

Authors:  Antonio A Fargiano; Kartiki V Desai; Jeffrey E Green
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

2.  Development of single-vector Tet-on inducible systems with high sensitivity to doxycycline.

Authors:  Jiun-Shuan Chao; Chun-Chieh Chao; Chu-Li Chang; Yi-Rong Chiu; Chiun-Jye Yuan
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

Review 3.  Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy.

Authors:  Pravin T P Kaumaya; Kevin Chu Foy
Journal:  Future Oncol       Date:  2012-08       Impact factor: 3.404

4.  Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma.

Authors:  Maddalena T Tilli; M Silvina Frech; Mary E Steed; Kathleen S Hruska; Michael D Johnson; Jodi A Flaws; Priscilla A Furth
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

Review 5.  Preclinical Models to Study Obesity and Breast Cancer in Females: Considerations, Caveats, and Tools.

Authors:  Erin D Giles; Elizabeth A Wellberg
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-11-04       Impact factor: 2.673

Review 6.  Pre-clinical applications of transgenic mouse mammary cancer models.

Authors:  C J Kavanaugh; K V Desai; A Calvo; P H Brown; C Couldrey; R Lubet; J E Green
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

7.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

Authors:  Jason I Herschkowitz; Karl Simin; Victor J Weigman; Igor Mikaelian; Jerry Usary; Zhiyuan Hu; Karen E Rasmussen; Laundette P Jones; Shahin Assefnia; Subhashini Chandrasekharan; Michael G Backlund; Yuzhi Yin; Andrey I Khramtsov; Roy Bastein; John Quackenbush; Robert I Glazer; Powel H Brown; Jeffrey E Green; Levy Kopelovich; Priscilla A Furth; Juan P Palazzo; Olufunmilayo I Olopade; Philip S Bernard; Gary A Churchill; Terry Van Dyke; Charles M Perou
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

8.  The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.

Authors:  Olga Aprelikova; Kenny Chen; Lara H El Touny; Constance Brignatz-Guittard; Justin Han; Tinghu Qiu; Howard H Yang; Maxwell P Lee; Min Zhu; Jeffrey E Green
Journal:  Clin Epigenetics       Date:  2016-04-14       Impact factor: 6.551
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.